Kunpeng Gene (Beijing) Scientific Instruments Co.

RocGene Technology Limited develops and manufactures Real-time PCR and Portable qPCR machines for research and diagnostics.

ActiveIndustrialManufacturingMedical Device

Website

Updated: Feb 17, 2026 ·

About

Kunpeng Gene (Beijing) Scientific Instruments Co. was established in 2016 and operates from its headquarters in Beijing, China. The company is dedicated to the development and manufacturing of advanced scientific instruments, with a core focus on technologies for nucleic acid extraction and molecular diagnostics. Its product portfolio includes specialized equipment such as Real-time PCR and Portable qPCR machines. These instruments are designed to cater to a broad range of applications, supporting both fundamental scientific research and practical diagnostic needs. Through its offerings, Kunpeng Gene aims to provide essential tools that enhance precision, efficiency, and accessibility in molecular analysis for the scientific community and healthcare sector.

Recent News & Mentions

Feb 9, 2026FundingKunpeng Gene (Beijing) Scientific Instruments Co. - Series B

Financial History

Kunpeng Gene (Beijing) Scientific Instruments Co. most recently raised Series B in February 2026.

Total Raised

N/A

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Feb 9, 2026	Series B

Financial History

Total Raised

N/A

Valuation

N/A

Deep Dive

Kunpeng Gene (Beijing) Scientific Instruments Co., founded in 2016, is a Beijing, China-based enterprise specializing in scientific instrument development and manufacturing. The company's primary focus lies in the critical areas of nucleic acid extraction and molecular diagnostics. This specialization positions Kunpeng Gene as a provider of essential tools for both research institutions and diagnostic laboratories. The company's product line features advanced solutions such as Real-time PCR and Portable qPCR machines. These instruments are engineered to deliver precise and reliable results, which are vital for various applications ranging from genetic research to disease detection and pathogen identification. By offering both stationary and portable options, Kunpeng Gene addresses diverse operational requirements within its target markets. Kunpeng Gene's commitment extends to supporting the broader scientific community and healthcare industry. Its instruments are designed to facilitate breakthroughs in scientific understanding and improve diagnostic capabilities, thereby contributing to public health and technological advancement. The company aims to enhance the efficiency and accessibility of molecular analysis across different settings. Since its inception, Kunpeng Gene has attracted external investment, demonstrating confidence in its technological capabilities and market potential. The company has successfully completed a Series B funding round, securing approximately $13,651,877. This capital infusion supports its ongoing research and development efforts, as well as its manufacturing and market expansion initiatives. The investment underscores the company's growth trajectory and its role in the evolving landscape of biotechnology and scientific instrumentation.

Sources

Frequently Asked Questions

What specific types of scientific instruments does Kunpeng Gene manufacture?

Kunpeng Gene manufactures instruments for nucleic acid extraction and molecular diagnostics, including Real-time PCR and Portable qPCR machines.

What is the dual purpose of Kunpeng Gene's instrument offerings?

The company's instruments are designed to support both advanced scientific research and practical diagnostic applications within the molecular biology field.

Has Kunpeng Gene received external funding, and if so, what was the approximate amount?

Yes, Kunpeng Gene has completed a Series B funding round, securing approximately $13,651,877.